2025年全球呼吸系統疾病檢測市場報告

預計未來幾年呼吸系統疾病檢測市場將強勁成長，到2029年將達到46.4億美元，複合年成長率為5.5%。預測期內的成長動力包括：空氣傳播呼吸道病毒的增加、對家用檢測解決方案的關注、精準醫療研究的加強、持續的環境衛生問題以及對早期療育和預防的重視。預測期內的主要趨勢包括就地檢驗、人工智慧 (AI) 整合、遠端監控技術、遠端醫療服務、客製化生物標記組以及增強型呼吸分析技術。

未來五年5.5%的成長率預測較先前的預測略有下降，下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。預計關稅壁壘將抑制美國診斷實驗室的發展，因為這會增加來自義大利和以色列的肺量計感測器和呼出氣一氧化氮分析儀的成本，從而延遲肺功能評估並增加呼吸系統護理支出。由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，關稅壁壘的影響也將更加廣泛。

呼吸系統疾病的盛行率正在上升，預計短期內將顯著提振呼吸系統疾病檢測市場。呼吸系統疾病包括影響呼吸系統的疾病，包括肺部、支氣管、氣管、喉、咽和鼻腔。呼吸系統疾病檢測的主要目的是早期發現和診斷，然後及時治療和管理。這種積極主動的方法不僅對於預防疾病進展至關重要，而且對於遏制傳染性呼吸道疾病的傳播和降低併發症風險也至關重要。例如，根據 NCD Alliance 於 2022 年 9 月發布的數據，肺癌是全球癌症死亡的主要原因，預計每年新增病例 220 萬例，死亡人數 180 萬人。慢性呼吸道疾病影響全球 5.5 億成年人，造成 420 萬人死亡，佔總數的 7%。因此，呼吸系統疾病盛行率的上升是呼吸系統疾病檢測市場的主要驅動力。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球呼吸系統疾病檢測：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球呼吸系統疾病檢測市場：成長率分析
• 全球呼吸偵測市場表現：規模與成長，2019-2024
• 全球呼吸系統疾病檢測市場預測：規模與成長，2024-2029年，2034年
• 全球呼吸測試：總目標市場（TAM）

第6章 市場細分

• 全球呼吸系統疾病檢測市場（依檢測類型）：績效與預測，2019-2024 年、2024-2029 年、2034 年
• 影像檢查
• 機械檢查
• 體外診斷測試
• 全球呼吸系統疾病檢測市場（依產品、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 肺容量
• 影像學
• 肺量計
• 尖峰流量
• 血氣
• 其他
• 全球呼吸系統疾病檢測市場的應用、績效及預測（2019-2024、2024-2029、2034）
• 慢性阻塞性肺病
• 肺癌
• 氣喘
• 患有肺結核的女人
• 其他
• 全球呼吸系統疾病檢測市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
• 醫院
• 醫生診所
• 臨床實驗室
• 其他
• 全球呼吸系統疾病檢測市場：影像檢查細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• X光
• 電腦斷層掃描（CT）
• 磁振造影（MRI）
• 正子斷層掃描（PET）
• 全球呼吸系統疾病檢測市場：機器測試細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 肺量計
• 峰值流量測量
• 肺容量測量
• 擴散能力測試
• 全球呼吸系統疾病檢測市場：體外診斷測試細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• PCR檢測
• 抗原檢測
• 抗體檢測
• 文化測試

第7章 區域和國家分析

• 全球呼吸系統疾病檢測市場：2019-2024 年、2024-2029 年和 2034 年區域表現和預測
• 全球呼吸系統疾病檢測市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 呼吸系統疾病檢測市場：競爭格局
• 呼吸系統疾病檢測市場：公司簡介
  • Medtronic plc
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Koninklijke Philips NV
  • ResMed Inc.

第31章：其他領先和創新企業

• Thermo Fisher Scientific Inc.
• Becton Dickinson and Company
• F. Hoffmann-La Roche Ltd.
• Nihon Kohden Corporation
• GE HealthCare Technologies Inc.
• Fisher & Paykel Healthcare Corporation Limited
• Qiagen NV
• Medical Graphics Corporation
• COSMED srl
• ndd Medizintechnik AG
• Vitalograph Ltd.
• MGC Diagnostics Corporation
• Vyaire Medical Inc.
• Masimo Corporation
• Hamilton Medical AG

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

• 2029年呼吸系統疾病檢測市場：提供新機會的國家
• 2029年呼吸系統疾病檢測市場：細分市場帶來新機會
• 2029年呼吸偵測市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

Respiratory disease testing encompasses the diagnostic process of evaluating various respiratory conditions through physical examinations. This procedure aids in the identification and measurement of lung conditions, assessing the speed at which a patient can exhale air. The results of these tests can assist clinicians in diagnosing respiratory diseases, even before patients exhibit symptoms.

The primary categories of tests involved in respiratory disease testing include imaging tests, mechanical tests, and in-vitro diagnostic tests. Imaging tests constitute a subset of diagnostic procedures that generate detailed images of various bodily regions. These tests utilize products such as lung volume imaging, spirometry, peak flow, blood gas, among others. They find applications in various respiratory conditions such as chronic obstructive pulmonary disease, lung cancer, asthma, and tuberculosis. These tests are typically conducted in hospitals, physician clinics, clinical laboratories, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The respiratory disease testing market research report is one of a series of new reports from The Business Research Company that provides respiratory disease testing market statistics, including respiratory disease testing industry global market size, regional shares, competitors with a respiratory disease testing market share, detailed respiratory disease testing market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory disease testing industry. This respiratory disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The respiratory disease testing market size has grown steadily in recent years. It will grow from $3.6 billion in 2024 to $3.74 billion in 2025 at a compound annual growth rate (CAGR) of 3.9%. The growth in the historic period can be attributed to environmental factors and pollution, tobacco smoking epidemic, occupational respiratory hazards, awareness and health education programs, government initiatives for disease control.

The respiratory disease testing market size is expected to see strong growth in the next few years. It will grow to $4.64 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rise in airborne respiratory viruses, focus on home-based testing solutions, increased research in precision medicine, continued environmental health concerns, focus on early intervention and prevention. Major trends in the forecast period include point-of-care testing, integration of artificial intelligence (AI), remote monitoring technologies, telehealth services, customized biomarker panels, enhanced breath analysis techniques.

The forecast of 5.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. diagnostic labs by increasing the cost of spirometry sensors and exhaled nitric oxide analyzers sourced from Italy and Israel, thereby slowing pulmonary function assessments and elevating respiratory care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The upward trajectory in the prevalence of respiratory diseases is poised to significantly boost the respiratory disease testing market in the foreseeable future. Respiratory diseases encompass medical conditions affecting the respiratory system, including the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. The primary purpose of respiratory disease testing is early detection and diagnosis, facilitating prompt treatment and management. This proactive approach not only helps impede disease progression but is also crucial for controlling the transmission of infectious respiratory diseases and reducing the risk of complications. For instance, in September 2022, data from the NCD Alliance revealed that lung cancer ranked as the leading cause of global cancer deaths, with an anticipated 2.2 million new cases and 1.8 million fatalities annually. Chronic respiratory disorders affected 550 million adults globally, resulting in 4.2 million deaths, accounting for 7% of the total. Therefore, the rising prevalence of respiratory diseases is a key driver for the respiratory disease testing market.

The increasing prevalence of tobacco smoking is anticipated to boost the growth of the respiratory disease testing market in the future. Tobacco smoking involves the combustion of dried leaves from the tobacco plant (Nicotiana tabacum) and inhaling the smoke produced. Respiratory disease testing is essential for managing the health of tobacco smokers, as it monitors changes in lung function over time, enabling healthcare professionals to evaluate the success of smoking cessation initiatives and modify treatment plans accordingly. For instance, in September 2024, the Centers for Disease Control and Prevention, a US government agency, reported that tobacco use remains the leading cause of preventable illness and death in the United States. In 2022, around 49.2 million adults, or 19.8%-nearly 1 in 5-indicated they used tobacco products. Consequently, the rising incidence of tobacco smoking is driving the expansion of the respiratory disease testing market.

Technological advancements are emerging as a prominent trend in the respiratory disease testing market, with major companies focusing on innovative solutions to enhance treatment protocols and elevate patient outcomes. A notable example is Respira Labs, a U.S.-based healthcare technology company, which introduced the AI-powered wearable device, Sylvee, in March 2022. Sylvee, worn as a chest strap, employs artificial intelligence and machine learning algorithms to analyze data from multiple sensors measuring breathing rate, volume, and patterns. This device aids in the early diagnosis and management of conditions such as chronic obstructive pulmonary disease (COPD), asthma, and COVID-19, utilizing advanced AI algorithms to analyze breath sounds and provide real-time feedback on lung function.

Major players in the respiratory disease testing market are actively engaged in developing advanced products, such as pulmonary function testing, to establish a competitive advantage. A case in point is Vitalograph Ltd., a UK-based provider of respiratory diagnostics, which launched the VitaloPFT series in March 2023. This series offers detailed pulmonary function testing options, providing healthcare providers with a cost-effective solution for advanced respiratory diagnostics. Its user-friendly design simplifies the testing process, enhancing accessibility for healthcare professionals.

In January 2023, CAIRE Inc., a prominent U.S.-based medical supply and manufacturing company, completed the acquisition of MGC Diagnostics Holdings for an undisclosed amount. This strategic move is driven by CAIRE Inc.'s objective to expand the scope of its product line, diversify its income streams, and fortify its position as a leading player in the medical technology sector, specifically focusing on respiratory and cardiorespiratory diagnostics. MGC Diagnostics Holdings Inc., the acquired entity, is a U.S.-based medical technology company specializing in offering comprehensive cardiorespiratory diagnostic solutions and respiratory disease testing products.

Major companies operating in the respiratory disease testing market include Medtronic plc, Abbott Laboratories, Seimens Healthineers AG, Koninklijke Philips N.V., ResMed Inc., Thermo Fisher Scientific Inc., Beckton Dickinson And Company, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, GE HealthCare Technologies Inc., Fisher And Paykel Healthcare Corporation Limited, Qiagen N.V., Medical Graphics Corporation, COSMED srl, ndd Medizintechnik AG, Vitalograph Ltd., MGC Diagnostics Corporation, Vyaire Medical Inc., Masimo Corporation, Hamilton Medical AG, Dragerwerk AG & Co. KGaA, Schiller AG, Nonin Medical Inc., Natus Medical Incorporated

North America was the largest region in the respiratory disease testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the global respiratory disease testing market during the forecast period. The regions covered in the respiratory disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the respiratory disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The respiratory disease testing market includes revenues earned by entities by providing services such as exhaled nitric oxide tests lung function tests. oxygen therapy, bronchoscopy, ultrasonography, nuclear lung scanning, and pulmonary artery angiography. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Respiratory Disease Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory disease testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory disease testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory disease testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test Type: Imaging Tests; Mechanical Tests; In-Vitro Diagnostic Tests
• 2) By Products: Lung Volume; Imaging; Spirometry; Peak Flow; Blood Gas; Other Products
• 3) By Application: Chronic Obstructive Pulmonary Disease; Lung Cancer; Asthma; Tuberculosis Female; Other Application
• 4) By End-User: Hospitals; Physician clinics; Clinical laboratories; Other End-User
• Subsegments:
• 1) By Imaging Tests: X-rays; Computed Tomography (CT) Scans; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scans
• 2) By Mechanical Tests: Spirometry; Peak Flow Measurement; Lung Volume Measurement; Diffusion Capacity Tests
• 3) By In-Vitro Diagnostic Tests: PCR Tests; Antigen Tests; Antibody Tests; Culture Tests
• Companies Mentioned: Medtronic plc; Abbott Laboratories; Seimens Healthineers AG; Koninklijke Philips N.V.; ResMed Inc.; Thermo Fisher Scientific Inc.; Beckton Dickinson And Company; F. Hoffmann-La Roche Ltd.; Nihon Kohden Corporation; GE HealthCare Technologies Inc.; Fisher And Paykel Healthcare Corporation Limited; Qiagen N.V.; Medical Graphics Corporation; COSMED srl; ndd Medizintechnik AG; Vitalograph Ltd.; MGC Diagnostics Corporation; Vyaire Medical Inc.; Masimo Corporation; Hamilton Medical AG; Dragerwerk AG & Co. KGaA; Schiller AG; Nonin Medical Inc.; Natus Medical Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Respiratory Disease Testing Market Characteristics

3. Respiratory Disease Testing Market Trends And Strategies

4. Respiratory Disease Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Respiratory Disease Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Respiratory Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Respiratory Disease Testing Market Growth Rate Analysis
• 5.4. Global Respiratory Disease Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Respiratory Disease Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Respiratory Disease Testing Total Addressable Market (TAM)

6. Respiratory Disease Testing Market Segmentation

• 6.1. Global Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Tests
• Mechanical Tests
• In-Vitro Diagnostic Tests
• 6.2. Global Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lung Volume
• Imaging
• Spirometry
• Peak Flow
• Blood Gas
• Other Products
• 6.3. Global Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Obstructive Pulmonary Disease
• Lung Cancer
• Asthma
• Tuberculosis Female
• Other Application
• 6.4. Global Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Physician clinics
• Clinical laboratories
• Other End-User
• 6.5. Global Respiratory Disease Testing Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• X-rays
• Computed Tomography (CT) Scans
• Magnetic Resonance Imaging (MRI)
• Positron Emission Tomography (PET) Scans
• 6.6. Global Respiratory Disease Testing Market, Sub-Segmentation Of Mechanical Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spirometry
• Peak Flow Measurement
• Lung Volume Measurement
• Diffusion Capacity Tests
• 6.7. Global Respiratory Disease Testing Market, Sub-Segmentation Of In-Vitro Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR Tests
• Antigen Tests
• Antibody Tests
• Culture Tests

7. Respiratory Disease Testing Market Regional And Country Analysis

• 7.1. Global Respiratory Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Respiratory Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Respiratory Disease Testing Market

• 8.1. Asia-Pacific Respiratory Disease Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Respiratory Disease Testing Market

• 9.1. China Respiratory Disease Testing Market Overview
• 9.2. China Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Respiratory Disease Testing Market

• 10.1. India Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Respiratory Disease Testing Market

• 11.1. Japan Respiratory Disease Testing Market Overview
• 11.2. Japan Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Respiratory Disease Testing Market

• 12.1. Australia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Respiratory Disease Testing Market

• 13.1. Indonesia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Respiratory Disease Testing Market

• 14.1. South Korea Respiratory Disease Testing Market Overview
• 14.2. South Korea Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Respiratory Disease Testing Market

• 15.1. Western Europe Respiratory Disease Testing Market Overview
• 15.2. Western Europe Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Respiratory Disease Testing Market

• 16.1. UK Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Respiratory Disease Testing Market

• 17.1. Germany Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Respiratory Disease Testing Market

• 18.1. France Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Respiratory Disease Testing Market

• 19.1. Italy Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Respiratory Disease Testing Market

• 20.1. Spain Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Respiratory Disease Testing Market

• 21.1. Eastern Europe Respiratory Disease Testing Market Overview
• 21.2. Eastern Europe Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Respiratory Disease Testing Market

• 22.1. Russia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Respiratory Disease Testing Market

• 23.1. North America Respiratory Disease Testing Market Overview
• 23.2. North America Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Respiratory Disease Testing Market

• 24.1. USA Respiratory Disease Testing Market Overview
• 24.2. USA Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Respiratory Disease Testing Market

• 25.1. Canada Respiratory Disease Testing Market Overview
• 25.2. Canada Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Respiratory Disease Testing Market

• 26.1. South America Respiratory Disease Testing Market Overview
• 26.2. South America Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Respiratory Disease Testing Market

• 27.1. Brazil Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Respiratory Disease Testing Market

• 28.1. Middle East Respiratory Disease Testing Market Overview
• 28.2. Middle East Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Respiratory Disease Testing Market

• 29.1. Africa Respiratory Disease Testing Market Overview
• 29.2. Africa Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Respiratory Disease Testing Market Competitive Landscape And Company Profiles

• 30.1. Respiratory Disease Testing Market Competitive Landscape
• 30.2. Respiratory Disease Testing Market Company Profiles
  • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. ResMed Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Respiratory Disease Testing Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific Inc.
• 31.2. Becton Dickinson and Company
• 31.3. F. Hoffmann-La Roche Ltd.
• 31.4. Nihon Kohden Corporation
• 31.5. GE HealthCare Technologies Inc.
• 31.6. Fisher & Paykel Healthcare Corporation Limited
• 31.7. Qiagen N.V.
• 31.8. Medical Graphics Corporation
• 31.9. COSMED srl
• 31.10. ndd Medizintechnik AG
• 31.11. Vitalograph Ltd.
• 31.12. MGC Diagnostics Corporation
• 31.13. Vyaire Medical Inc.
• 31.14. Masimo Corporation
• 31.15. Hamilton Medical AG

32. Global Respiratory Disease Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Respiratory Disease Testing Market

34. Recent Developments In The Respiratory Disease Testing Market

35. Respiratory Disease Testing Market High Potential Countries, Segments and Strategies

• 35.1 Respiratory Disease Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Respiratory Disease Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Respiratory Disease Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer